Effective from November 20, 2020, the equity shares of Gland Pharma Ltd (Scrip Code: 543245) are listed and admitted to dealings on the Bombay Stock Exchange in the list of 'B' Group Securities.
The company issued shares at a price of Rs. 1500/- per share (Face Value of Rs. 1/- and premium of Rs. 1,499/-) in the recently concluded public issue.
The above-mentioned scrip will be a part of Special Pre-open Session (SPOS) on Friday, November 20, 2020.